Use of clindamycin and gentamicin in pediatric colonic surgery

Area of Science:

• Pediatric Surgery
• Infectious Diseases
• Clinical Pharmacology

Background:

• Perforated appendicitis in pediatric patients can lead to serious peritoneal infections.
• Bacteroides fragilis is a common pathogen in intra-abdominal infections, particularly following appendiceal perforation.
• Effective antibiotic therapy is crucial for managing pediatric surgical site infections.

Purpose of the Study:

• To evaluate the efficacy and safety of combined clindamycin and gentamicin in treating pediatric surgical patients.
• To assess the clinical response in patients with perforated appendicitis and B. fragilis isolation.
• To determine if this antibiotic combination is a suitable choice for these specific infections.

Main Methods:

• A cohort of 25 pediatric surgical patients received treatment with clindamycin and gentamicin.
• Bacteriological analysis was performed on peritoneal fluid samples from patients with perforated appendicitis.
• Clinical outcomes and adverse events were monitored throughout the treatment period.

Main Results:

• A rapid clinical response was observed in all 25 treated pediatric patients.
• Bacteroides fragilis was identified in 9 out of 11 patients with perforated appendicitis.
• No adverse side effects were reported during the course of antibiotic treatment.

Conclusions:

• The combination of clindamycin and gentamicin demonstrated high efficacy in treating pediatric surgical infections.
• This antibiotic regimen is a promising option for perforated appendicitis, especially when B. fragilis is implicated.
• The observed safety profile supports the use of clindamycin and gentamicin as first-line agents in these pediatric cases.